Written question asked by Alison Thewliss (Scottish National Party) on Friday, 16 April 2021, in the House of Commons. It was due for an answer on Wednesday, 21 April 2021 (named day). It was answered by Steve Barclay (Conservative) on Wednesday, 21 April 2021 on behalf of the Treasury.
Thalidomide
- Question
-
To ask the Chancellor of the Exchequer, pursuant to the Answer of 11 March to Question 164514, what the Barnett Consequentials are for (a) Scotland, (b) Wales and (c) Northern Ireland of his Budget 2021 announcement on funding for the Thalidomide Health Grant Renewal.
- Answer
-
Further to my previous answer, at spending reviews the Barnett formula is generally applied to the overall change in each department’s funding, rather than being applied at programme level.
It is not therefore possible to specify the Barnett consequentials generated by the funding for the Thalidomide Health Grant Renewal at the 2020 Spending Review. However, I can confirm that the 2020 Spending Review provided the devolved administrations with a combined additional £4.7 billion for 2021-22 through the Barnett formula.
Funding for 2022-23 onwards will be determined at the upcoming spending review.
Secondary information
- Type
- Written question
- Reference
- 182065
- Session
- 2019-21
- Related items
- Subjects
- Devolution Finance Thalidomide
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-04-21 12:53:19 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/182065
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/182065
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/182065